- Prevalence: In 2019, 37.3 million Americans, or 11.3% of the population, had diabetes.
- Nearly 1.9 million Americans have type 1 diabetes, including about 244,000 children and adolescents
- Diagnosed and undiagnosed: Of the 37.3 million adults with diabetes, 28.7 million were diagnosed, and 8.5 million were undiagnosed.
- Prevalence in seniors: The percentage of Americans age 65 and older remains high, at 29.2%, or 15.9 million seniors (diagnosed and undiagnosed).
- New cases: 1.4 million Americans are diagnosed with diabetes every year.
- Prediabetes: In 2019, 96 million Americans age 18 and older had prediabetes.
- About 283,000 Americans under age 20 are estimated to have diagnosed diabetes, approximately 0.35% of that population.
- In 2014–2015, the annual incidence of diagnosed diabetes in youth was estimated at 18,200 with type 1 diabetes, 5,800 with type 2 diabetes.
The rates of diagnosed diabetes in adults by race/ethnic background are:
- 14.5% of American Indians/Alaskan Natives
- 12.1% of non-Hispanic blacks
- 11.8% of Hispanics
- 9.5% of Asian Americans
- 7.4% of non-Hispanic whites
The breakdown among Asian Americans:
- 5.6% of Chinese
- 10.4% of Filipinos
- 12.6% of Asian Indians
- 9.9% of other Asian Americans
The breakdown among Hispanic adults:
- 8.3% of Central and South Americans
- 6.5% of Cubans
- 14.4% of Mexican Americans
- 12.4% of Puerto Ricans
Deaths
Diabetes was the seventh leading cause of death in the United States in 2019 based on the 87,647 death certificates in which diabetes was listed as the underlying cause of death. In 2019, diabetes was mentioned as a cause of death in a total of 282,801 certificates.
Cost of diabetes
Updated March 22, 2018
$327 billion: Total cost of diagnosed diabetes in the United States in 2017
$237 billion was for direct medical costs
$90 billion was in reduced productivity
After adjusting for population age and sex differences, average medical expenditures among people with diagnosed diabetes were 2.3 times higher than what expenditures would be in the absence of diabetes.
Read more about the results of our study "Economic Costs of Diabetes in the U.S. in 2017."
For additional information
For additional information, read the CDC National Diabetes Statistics Report (2022).
Page updated 7/28/22.
National Diabetes Statistics Report. 2020: Estimates of Diabetes and Its Burden in the United States. Atlanta, GA: U.S. Department of Health and Human Services Centers for Disease Control and Prevention; 2020.
Selvin E, Ali MK. Declines in the Incidence of Diabetes in the U.S.-Real Progress or Artifact? Diabetes Care. 2017;40(9):1139–43.
Article Google Scholar
Piccolo RS, Pearce N, Araujo AB, McKinlay JB. The Contribution of Biogeographic Ancestry and Socioeconomic Status to Racial/Ethnic Disparities in Type 2 Diabetes: Results from the Boston Area Community Health (BACH) Survey. Ann Epidemiol. 2014;24(9):648-54.e1.
Article Google Scholar
Lanting LC, Joung IMA, Mackenbach JP, Lamberts SWJ, Bootsma AH. Ethnic Differences in Mortality, End-Stage Complications, and Quality of Care Among Diabetic Patients: A review. Diabetes Care. 2005;28(9):2280–8.
Article Google Scholar
Emanuele N, Moritz T, Klein R, Davis MD, Glander K, Khanna A, et al. Ethnicity, race, and clinically significant macular edema in the Veterans Affairs Diabetes Trial (VADT). Diabetes Res Clin Pract. 2009;86(2):104–10.
Article Google Scholar
Harris MI, Klein R, Cowie CC, Rowland M, Byrd-Holt DD. Is the Risk of Diabetic Retinopathy Greater in Non-Hispanic Blacks and Mexican Americans Than in Non-Hispanic Whites With Type 2 Diabetes?: A U.S. population study. Diabetes Care. 1998;21(8):1230–5.
CAS Article Google Scholar
Young BA, Maynard C, Boyko EJ. Racial Differences in Diabetic Nephropathy, Cardiovascular Disease, and Mortality in a National Population of Veterans. Diabetes Care. 2003;26(8):2392–9.
Article Google Scholar
Gillum RF, Mussolino ME, Madans JH. Diabetes mellitus, coronary heart disease incidence, and death from all causes in African American and European American women The NHANES I Epidemiologic Follow-up Study. J Clin Epidemiol. 2000;53(5):511–8.
CAS Article Google Scholar
Karter AJ, Ferrara A, Liu JY, Moffet HH, Ackerson LM, Selby JV. Ethnic Disparities in Diabetic Complications in an Insured Population. JAMA: the journal of the American Medical Association. 2002;287(19):2519–27.
Article Google Scholar
Ness J, Aronow WS. Prevalence of coronary artery disease, ischemic stroke, peripheral arterial disease, and coronary revascularization in older African-Americans, Asians, Hispanics, Whites, Men, and Women. The American journal of cardiology. 1999;84(8):932–3.
CAS Article Google Scholar
Cook CB, Erdman DM, Ryan GJ, Greenlund KJ, Giles WH, Gallina DL, et al. The pattern of dyslipidemia among urban African-Americans with type 2 diabetes. Diabetes Care. 2000;23(3):319–24.
CAS Article Google Scholar
Fryar CD, Hirsch R, Eberhardt MS, Yoon SS, Wright JD. Hypertension, high serum total cholesterol, and diabetes: racial and ethnic prevalence differences in U.S. adults, 1999-2006. NCHS data brief. 2010(36):1–8.
Kirk JK, Bell RA, Bertoni AG, Arcury TA, Quandt SA, Goff DC, et al. Ethnic Disparities: Control of Glycemia, Blood Pressure, and LDL Cholesterol Among US Adults with Type 2 Diabetes. The Annals of pharmacotherapy. 2005;39(9):1489–501.
CAS Article Google Scholar
The prevalence of. retinopathy in impaired glucose tolerance and recent-onset diabetes in the Diabetes Prevention Program. Diabetic medicine. 2007;24(2):137–44.
Article Google Scholar
Harris MI, Klein R, Welborn TA, Knuiman MW. Onset of NIDDM occurs at Least 4-7 yr Before Clinical Diagnosis. Diabetes Care. 1992;15(7):815–9.
CAS Article Google Scholar
American Diabetes A. Standards of Medical Care in Diabetes—2020 Abridged for Primary Care Providers. Clinical diabetes. 2020;38(1):10–38.
Article Google Scholar
Daskivich LP, Mangione CM. The Promise of Primary Care–Based Screening for Diabetic Retinopathy: The Devil Will Be in the Details Comment on “Telemedicine and Retinal Imaging for Improving Diabetic Retinopathy Evaluation”. Arch Intern Med. 2012;172(21):1678–80.
Article Google Scholar
National Committee for Quality Assurance, The State of Health Care. Quality 2020 Report [Available from: //www.ncqa.org/hedis/measures/comprehensive-diabetes-care/.
Parsons VL, Moriarity C, Jonas K, Moore TF, Davis KE, Tompkins L. Design and estimation for the national health interview survey, 2006-2015. Vital and health statistics Series 2 Data evaluation and methods research. 2014(165):1.
North Carolina Institute of Medicine. Healthy North Carolina 2030: A Path Toward Health. Morrisville, NC: North Carolina Institute of Medicine; 2020.; 2020.
Quiñones AR, Markwardt S, Botoseneanu A. Diabetes-Multimorbidity Combinations and Disability Among Middle-aged and Older Adults. Journal of general internal medicine: JGIM. 2019;34(6):944–51.
Article Google Scholar
Gregg EW, Geiss LS, Saaddine J, Fagot-Campagna A, Beckles G, Parker C, et al. Use of diabetes preventive care and complications risk in two African-American communities. Am J Prev Med. 2001;21(3):197–202.
CAS Article Google Scholar
Golden SH, Brown A, Cauley JA, Chin MH, Gary-Webb TL, Kim C, et al. Health Disparities in Endocrine Disorders: Biological, Clinical, and Nonclinical Factors—An Endocrine Society Scientific Statement. The journal of clinical endocrinology metabolism. 2012;97(9):E1579-E639.
Article Google Scholar
Pugh JA, Tuley MR, Hazuda HP, Stern MP. The influence of outpatient insurance coverage on the microvascular complications of non-insulin-dependent diabetes in Mexican Americans. J Diabetes Complicat. 1992;6(4):236–41.
CAS Article Google Scholar
Buchmueller TC, Levinson ZM, Levy HG, Wolfe BL. Effect of the Affordable Care Act on Racial and Ethnic Disparities in Health Insurance Coverage. American journal of public health (1971). 2016;106(8):1416-21.
Peterson KA, Carlin C, Solberg LI, Jacobsen R, Kriel T, Eder M. Redesigning Primary Care to Improve Diabetes Outcomes (the UNITED Study). Diabetes Care. 2020;43(3):549–55.
Article Google Scholar
Smedley BD, Stith AY, Care CoU, Eliminating R. Ethnic Disparities in H. Unequal Treatment: Confronting Racial and Ethnic Disparities in Health Care. Washington: National Academies Press, Elsevier Limited, National Medical Association; 2002. 666–8.
Google Scholar
Trivedi AN, Ayanian JZ. Perceived discrimination and use of preventive health services. Journal of general internal medicine: JGIM. 2006;21(6):553–8.
Article Google Scholar
Green AR, Nze C. Language-Based Inequity in Health Care: Who Is the “Poor Historian”? AMA journal of ethics. 2017;19(3):263–71.
Article Google Scholar
Harris MI. Racial and Ethnic Differences in Health Care Access and Health Outcomes for Adults With Type 2 Diabetes. Diabetes Care. 2001;24(3):454–9.
CAS Article Google Scholar
Resnick HE, Valsania P, Phillips CL. Diabetes Mellitus and Nontraumatic Lower Extremity Amputation in Black and White Americans: The National Health and Nutrition Examination Survey Epidemiologic Follow-up Study, 1971-1992. Archives of internal medicine (1960). 1999;159(20):2470-5.
Arya S, Binney Z, Khakharia A, Brewster LP, Goodney P, Patzer R, et al. Race and Socioeconomic Status Independently Affect Risk of Major Amputation in Peripheral Artery Disease. Journal of the American Heart Association. 2018;7(2):n/a
Littman AJ, Knott CJ, Boyko EJ, Hawes SE. Associations Between Racial and Ethnic Groups and Foot Self-Inspection in People With Diabetes. Diabetes Care. 2020;43(5):956–63.
Article Google Scholar
Brancati FL, Kao WHL, Folsom AR, Watson RL, Szklo M. Incident Type 2 Diabetes Mellitus in African American and White Adults: The Atherosclerosis Risk in Communities Study. JAMA: the journal of the American Medical Association. 2000;283(17):2253–9.
CAS Article Google Scholar
US Department of Health and Human Services Office for Human Research Protections. Human subject regulations decision charts. //www.hhs.gov/ohrp/sites/default/files/full-2016-decision-charts.pdf. Updated February 16, 2016. Accessed September 28, 2021.
Page 2
N* | 4289 | 1337 | 1196 | |
Mean Age (years) | 58.4 | 54.8 | 52.0 | <0.001 |
Sex | <0.001 | |||
Female | 2124 (46.8) | 801 (55.7) | 660 (50.3) | |
Has health Insurance† | 3893 (93.2) | 1124 (88.1) | 854 (75.9) | <0.001 |
General health status‡ | <0.001 | |||
Excellent/very good | 1237 (28.7) | 256 (19.4) | 273 (25.9) | |
Good/fair | 2645 (62.1) | 922 (69.3) | 819 (66.2) | |
Poor | 404 (9.1) | 158 (11.3) | 104 (7.9) | |
Region | <0.001 | |||
Northeast | 718 (17.2) | 172 (15.8) | 165 (14.0) | |
Midwest | 1212 (29.0) | 209 (17.0) | 100 (9.8) | |
South | 1539 (38.2) | 833 (58.3) | 438 (37.6) | |
West | 820 (15.6) | 123 (8.9) | 493 (38.6) | |
Hypertension§ | 3033 (70.1) | 1076 (78.1) | 716 (58.9) | <0.001 |
Taking oral diabetes medication | 1093 (24.5) | 339 (24.8) | 327 (28.3) | 0.07 |
Taking insulin | 567 (12.2) | 252 (17.2) | 141 (11.5) | <0.001 |
BMI|| | 0.11 | |||
< 18.5 | 20 (0.4) | 3 (0.2) | 4 (0.4) | |
18.5 – 24.9 | 423 (9.3) | 129 (9.3) | 127 (9.5) | |
25.0 – 29.9 | 1166 (28.9) | 346 (25.6) | 367 (31.8) | |
≥ 30.0 | 2468 (61.4) | 808 (64.9) | 642 (58.3) | |
Number of comorbidities¶ | <0.001 | |||
0 | 1216 (30.0) | 517 (41.5) | 551 (44.5) | |
1 | 1493 (35.6) | 433 (31.1) | 406 (35.5) | |
2-3 | 1273 (27.6) | 318 (23.0) | 205 (17.4) | |
≥ 4 | 307 (6.8) | 69 (4.4) | 34 (2.5) | |
Married | 2111 (61.1) | 392 (41.0) | 548 (57.1) | <0.001 |
Seen/talked to eye doctor (past 12 months)# | 2441 (57.1) | 662 (48.8) | 496 (41.3) | <0.001 |
Seen/talked to foot doctor (past 12 months)** | 687 (16.5) | 281 (18.9) | 183 (13.5) | 0.02 |
BP check by health profession (past 12 months)†† | 4116 (97.6) | 1271 (96.3) | 1060 (90.4) | <0.001 |
Cholesterol check by health profession (past 12 months)‡‡ | 3872 (92.9) | 1203 (91.9) | 997 (85.6) | <0.001 |
- Notes:
- *N=6,822 because 519 out of 7,341 participants have race/ethnicity data missing. Countsare not weighted, but percentages by race/ethnicity are weighted.
- † 271 participants missing data on insurance coverage
- ‡ 4 participants missing data on health status
- § 3 participants missing hypertension status information
- || 319 participants missing data on body mass index (BMI)
- ¶ Number of comorbidities related to diabetes and represents count of ever told about heartdisease, angina, cancer, high cholesterol, or kidney disease
- # 82 participants missing data on having a visit to an eye doctor in the past 12 months
- ** 73 participants missing data on having a visit to a foot doctor in the past 12 months
- †† 124 participants missing data on having blood pressure check by a health professional inthe past 12 months
- ‡‡ 183 participants missing data on having cholesterol check by a health professional in thepast 12 months